New Prostate Cancer Screening Test Could Reduce Biopsies
Prostate Cancer

New Prostate Cancer Screening Test Could Reduce Biopsies

A new prostate cancer screening test known as IsoPSA could reduce the number of prostate biopsies that are performed by 50 percent and thus save many men from unnecessary treatment that is associated with life-altering side effects. This new test is better able than the current PSA (prostate-specific antigen) test to distinguish prostate cancer from…

Does Soy Reduce PSA Levels?
Prostate Cancer

Does Soy Reduce PSA Levels?

A supplement consisting of a synthetic version of genistein, an isoflavone found in soybeans, reduced prostate-specific antigen (PSA) levels in men with early prostate cancer and elevated PSA levels, according to a new study in the journal Nutrition and Cancer. This finding could help explain the results of research indicating a reduced risk of prostate…

New PSA Test (Prostate Health Index) Approved by FDA
Prostate Cancer

New PSA Test (Prostate Health Index) Approved by FDA

Men are often told that while the prostate-specific antigen (PSA) test is not perfect nor specific for detecting prostate cancer, it’s the best test available. Now, however, a new PSA test, called the Prostate Health Index (phi), has received premarket approval from the Food and Drug Administration (FDA). The Prostate Health Index was designed to differentiate prostate…

10 Things That Lower PSA Levels (And Some Things That Increase It)
Men's Health

10 Things That Lower PSA Levels (And Some Things That Increase It)

An elevated PSA (prostate-specific antigen) can be an early warning sign that something is not quite right with the prostate, but it also may have no direct association with the prostate at all. That is, although there is the possibility that an elevated PSA value is an indication of prostatitis, an enlarged prostate, or prostate…

Does The PSA Test Work?
Men's Health

Does The PSA Test Work?

Some experts argue that the PSA (prostate-specific antigen) test is not that reliable because it can give false positive (indicating cancer that is not there) and false negative (missing prostate cancer that is there) results. In fact, roughly 80 percent of the 1.6 million men who undergo prostatic biopsy in the United States each year…